Chemotherapy pain may be eased by jet-lag drug
Painful side effects from cancer medicines could be tackled with a drug that eases the effects of jetlag...
List view / Grid view
News
Cypralis granted new Innovate UK feasibility stage award for chronic pancreatitis
Cypralis, has been awarded funding by Innovate UK to develop cyclophilin inhibitors targeting fibrotic diseases...
ALA-artemisinin combination therapy for cancer identified
Artemisinin, a potent anti-malarial drug, has been widely hailed as a promising alternative cancer treatment...
MRI effective in detecting postpartum breast cancers
Pregnancy-associated breast cancer, which is rare but often aggressive, has been detected with MRI...
One vaccine injection could carry many doses
Engineers have invented a new 3-D fabrication method that can generate a novel type of drug-carrying particle that could allow multiple doses of a drug or vaccine to be delivered...
FDA approves first biosimilar for the treatment of cancer
Mvasi, a biosimilar to the cancer drug Avastin, is approved for certain colorectal, lung, brain, kidney and cervical cancers…
Bluebird bio joins the ABPI as a full member
The Association of the British Pharmaceutical Industry (ABPI) has admitted the American biotech bluebird bio, Inc. as a full member...
FDA-approved drug may block resistance to anti-angiogenesis therapy
General study identifies targetable pathway that induces immunosuppressive environment in colorectal cancer...
Type 2 diabetes drug provides significant benefits to type 1 diabetic patients
A study has found that a majority of patients with Type 1 diabetes who were treated with dapagliflozin, a Type 2 diabetes medicine, had a significant decline in their blood sugar levels...
New microchip technology could be used to track ‘smart pills’
Researchers have developed microscale devices that relay their location in the body...
BC Platforms launches global genomics and clinical data analytics resource
A world leader in genomic data has launched BC|RQUEST, a unique resource that enables integrated analytics of genomic and clinical data...
Magnetic cellular ‘Legos’ for the regenerative medicine of the future
By incorporating magnetic nanoparticles in cells researchers have succeeded in creating cellular magnetic "Legos."...
Cancer drug stimulates tripolar mode of mitosis
Taxanes inhibit cell division and make cancer cells sensitive to radiation therapy, a current study has investigated the underlying mechanisms of this action...
Nivolumab superior to ipilimumab for adjuvant treatment of melanoma
Adjuvant nivolumab has been found to be more superior than ipilimumab in the standard of care in patients with surgically resected stage III/IV melanoma...
Paul Royall joins European Pharmaceutical Review
Dr Paul Royall, Senior Lecturer in Pharmaceutics at King’s College London, and Programme Director of the MSc in Pharmaceutical Analysis and Quality Control, has joined European Pharmaceutical Review's Editorial Advisory Board.
